In addition, gene silencing data correlated mPRδ activity with MEK and ERK1/2 signaling pathway involved in proliferation and migration of tumor cells, suggesting its potential role in prostate cancer development and serving as potential prognosis biomarker [150] (Figure 3). This evidence concerns the gene MAPK3 and Familial prostate cancer.